Skip to main content

and
  1. Article

    Open Access

    Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic

    Racialized communities, including Black Canadians, have disproportionately higher COVID-19 cases. We examined the extent to which SARS-CoV-2 infection has affected the Black Canadian community and the factors ...

    Upton D. Allen, Michelle Barton, Julia Upton in Journal of Racial and Ethnic Health Dispar… (2024)

  2. Article

    Open Access

    Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

    Julia Ludwig, Stephen W. Scally, Giulia Costa, Sandro Hoffmann in npj Vaccines (2023)

  3. Article

    Open Access

    Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

    The development of an effective and durable vaccine remains a central goal in the fight against malaria. Circumsporozoite protein (CSP) is the major surface protein of sporozoites and the target of the only li...

    Julia Ludwig, Stephen W. Scally, Giulia Costa, Sandro Hoffmann in npj Vaccines (2023)

  4. Article

    Open Access

    Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease

    The COVID-19 pandemic has highlighted the urgent need for the identification of new antiviral drug therapies for a variety of diseases. COVID-19 is caused by infection with the human coronavirus SARS-CoV-2, wh...

    Michael G. Sugiyama, Haotian Cui, Dar’ya S. Redka, Mehran Karimzadeh in Scientific Reports (2021)

  5. Article

    Open Access

    Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

    SARS-CoV-2, the virus responsible for COVID-19, has caused a global pandemic. Antibodies can be powerful biotherapeutics to fight viral infections. Here, we use the human apoferritin protomer as a modular subu...

    Edurne Rujas, Iga Kucharska, Yong Zi Tan, Samir Benlekbir in Nature Communications (2021)

  6. Article

    Open Access

    A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands

    Sialic acid-binding immunoglobulin-type lectins (Siglecs) are immunomodulatory receptors that are regulated by their glycan ligands. The connections between Siglecs and human disease motivate improved methods ...

    Emily Rodrigues, Jaesoo Jung, Hea** Park, Caleb Loo in Nature Communications (2020)

  7. Article

    Open Access

    Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

    The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, and delivers a positive co-stimulatory signal to activated T cells upon binding to its ligand (ICOS-L). Dysregulation of this pathway ...

    Edurne Rujas, Hong Cui, Taylor Sicard, Anthony Semesi in Nature Communications (2020)

  8. No Access

    Article

    Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs

    The circumsporozoite protein of the human malaria parasite Plasmodium falciparum (PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in animal models. However, the limited ef...

    Rajagopal Murugan, Stephen W. Scally, Giulia Costa, Ghulam Mustafa in Nature Medicine (2020)

  9. No Access

    Article

    Antibodies against Plasmodium falciparum malaria at the molecular level

    Malaria is a vector-borne disease of global importance, with the vast majority of its life-threatening cases caused by infection with Plasmodium falciparum parasites. Repeated exposure to P. falciparum leads to n...

    Jean-Philippe Julien, Hedda Wardemann in Nature Reviews Immunology (2019)

  10. Article

    Open Access

    Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25

    Transmission-blocking vaccines have the potential to be key contributors to malaria elimination. Such vaccines elicit antibodies that inhibit parasites during their development in Anopheles mosquitoes, thus break...

    Brandon McLeod, Kazutoyo Miura, Stephen W. Scally, Alexandre Bosch in Nature Communications (2019)

  11. Article

    Open Access

    Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions

    Antibodies against the Membrane-Proximal External Region (MPER) of the Env gp41 subunit neutralize HIV-1 with exceptional breadth and potency. Due to the lack of knowledge on the MPER native structure and acce...

    Pablo Carravilla, Jakub Chojnacki, Edurne Rujas, Sara Insausti in Nature Communications (2019)

  12. Article

    Open Access

    Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

    Interventions that can block the transmission of malaria-causing Plasmodium falciparum (Pf) between the human host and Anopheles vector have the potential to reduce the incidence of malaria. Pfs48/45 is a gametoc...

    Prasun Kundu, Anthony Semesi, Matthijs M. Jore, Merribeth J. Morin in Nature Communications (2018)

  13. Article

    Open Access

    Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25

    The Plasmodium falciparum Pfs25 protein (Pfs25) is a leading malaria transmission-blocking vaccine antigen. Pfs25 vaccination is intended to elicit antibodies that inhibit parasite development when ingested by An...

    Stephen W. Scally, Brandon McLeod, Alexandre Bosch, Kazutoyo Miura in Nature Communications (2017)

  14. Article

    Open Access

    Molecular basis of human CD22 function and therapeutic targeting

    CD22 maintains a baseline level of B-cell inhibition to keep humoral immunity in check. As a B-cell-restricted antigen, CD22 is targeted in therapies against dysregulated B cells that cause autoimmune diseases...

    June Ereño-Orbea, Taylor Sicard, Hong Cui in Nature Communications (2017)

  15. No Access

    Article

    The structural basis of modified nucleosome recognition by 53BP1

    A cryo-electron microscopy structure of the DNA damage repair protein 53BP1 bound to a nucleosome illuminates the way 53BP1 recognizes two types of histone modifications (a methyl group and a ubiquitin moiety)...

    Marcus D. Wilson, Samir Benlekbir, Amélie Fradet-Turcotte, Alana Sherker in Nature (2016)

  16. No Access

    Article

    Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env

    HIV’s envelope glycoprotein (Env) is the sole target for neutralizing antibodies. The structures of many broadly neutralizing antibodies (bNAbs) in complex with truncated Env subunits or components have been r...

    Miklos Guttman, Albert Cupo, Jean-Philippe Julien in Nature Communications (2015)

  17. Article

    Open Access

    Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

    The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutralizing antibodies (NAbs). No candidate HIV-1 immunogen has yet induced potent, broadly active NAbs (bNAbs). P...

    Anila Yasmeen, Rajesh Ringe, Ronald Derking, Albert Cupo in Retrovirology (2014)

  18. No Access

    Article

    Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

    Some broadly neutralizing antibodies to HIV-1 recognize glycan-dependent epitopes on gp120. Now X-ray crystallography and EM approaches, along with functional analyses, reveal how one particular antibody (PGT1...

    Leopold Kong, Jeong Hyun Lee, Katie J Doores in Nature Structural & Molecular Biology (2013)

  19. Article

    Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary s...

    Jason S. McLellan, Marie Pancera, Chris Carrico, Jason Gorman in Nature (2011)

  20. No Access

    Article

    Broad neutralization coverage of HIV by multiple highly potent antibodies

    Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we probed the neutralizing antibody repertoires of fou...

    Laura M. Walker, Michael Huber, Katie J. Doores, Emilia Falkowska, Robert Pejchal in Nature (2011)